We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
-6.74%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$608M
AUM Growth
+$8.42M
Cap. Flow
-$26M
Cap. Flow %
-4.28%
Top 10 Hldgs %
46.74%
Holding
185
New
59
Increased
29
Reduced
34
Closed
61

Top Buys

Rank Stock Value
1
RUN icon
Sunrun
RUN
+$12.8M
2
TEAM icon
Atlassian
TEAM
+$10M
3
VYX icon
NCR Voyix
VYX
+$7.08M
4
THC icon
Tenet Healthcare
THC
+$6.28M
5
WOLF icon
Wolfspeed
WOLF
+$6.24M

Sector Composition

Rank Sector Weight
1 Miscellaneous 33.63%
2 Technology 25.39%
3 Healthcare 14.59%
4 Consumer Staples 6.23%
5 Energy 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBT icon
1
CALL
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$312M
$65.4M 10.76%
2,500,000
-750,000
-23% -$19.1M
STKL
2
DELISTED
SunOpta
STKL
$37.9M 6.23%
4,870,500
-434,500
-8% -$2.86M
SPY icon
3
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$808B
$37.7M 6.21%
+100,000
New +$41M
CTLP
4
DELISTED
Cantaloupe
CTLP
$32.6M 5.36%
5,818,200
+611,700
+12% +$3.25M
MBII
5
DELISTED
Marrone Bio Innovations, Inc.
MBII
$21.3M 3.5%
18,335,767
RUN icon
6
CALL
Sunrun
RUN
$2.06B
$21M 3.46%
+900,000
New +$21.6M
QQQ icon
7
CALL
Invesco QQQ Trust
QQQ
$488B
$21M 3.46%
+75,000
New +$23.3M
RUN icon
8
Sunrun
RUN
$2.06B
$16.3M 2.68%
697,000
+532,000
+322% +$12.8M
ALT icon
9
Altimmune
ALT
$636M
$15.7M 2.58%
1,339,000
-14,000
-1% -$86.3K
STAA icon
10
STAAR Surgical
STAA
$1.14B
$15.3M 2.51%
215,000
-46,450
-18% -$2.99M
SEDG icon
11
SolarEdge
SEDG
$2.13B
$13.7M 2.25%
50,050
+20,050
+67% +$5.48M
VST icon
12
Vistra
VST
$49.8B
$11.8M 1.95%
518,000
+90,500
+21% +$2.24M
XBI icon
13
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.9B
$11.1M 1.83%
+150,000
New +$11.3M
AZN icon
14
AstraZeneca
AZN
$248B
$11M 1.8%
83,000
-7,500
-8% -$984K
SGRY icon
15
Surgery Partners
SGRY
$1.88B
$10.1M 1.67%
350,000
+70,000
+25% +$3.06M
THC icon
16
Tenet Healthcare
THC
$21.2B
$10M 1.64%
190,200
+90,200
+90% +$6.28M
EOG icon
17
EOG Resources
EOG
$77.3B
$9.43M 1.55%
85,300
+10,300
+14% +$1.28M
AMPS
18
DELISTED
Altus Power
AMPS
$9.05M 1.49%
1,435,000
+50,000
+4% +$334K
TEAM icon
19
Atlassian
TEAM
$45.5B
$8.8M 1.45%
+46,900
New +$10M
EVA
20
DELISTED
Enviva Inc.
EVA
$8.58M 1.41%
150,000
-15,000
-9% -$1.13M
AAPL icon
21
PUT
Apple
AAPL
$4.85T
$8.34M 1.37%
+61,000
New +$9.24M
PCRX icon
22
Pacira BioSciences
PCRX
$1.01B
$7.87M 1.3%
135,000
+35,000
+35% +$2.29M
HLIT icon
23
Harmonic Inc
HLIT
$1.31B
$7.6M 1.25%
876,500
-115,250
-12% -$1.04M
WOLF icon
24
Wolfspeed
WOLF
$1.35B
$7.3M 1.2%
115,000
+75,000
+188% +$6.24M
DT icon
25
Dynatrace
DT
$14.8B
$6.95M 1.14%
176,200
-35,800
-17% -$1.43M

Similar funds

Ardsley Advisory Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Ardsley Advisory Partners held 185 positions worth $608M, up 1.4% from $599M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Ardsley Advisory Partners withdrew a net $26M in Q2 2022, closing 61 positions and reducing 34 holdings. Its most notable exit was ProShares Trust UltraShort Lehman 20+ Year Treasury, an estimated $21.1M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 24% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Ardsley Advisory Partners opened a new position in Atlassian worth $8.8M.

  • Ardsley Advisory Partners's largest Q2 2022 buy was Atlassian: 46,900 shares worth $8.8M.
  • Ardsley Advisory Partners added most to Sunrun in Q2 2022, an estimated $12.8M increase.
  • Ardsley Advisory Partners's biggest Q2 2022 reduction was Ambarella, cutting an estimated $6.8M.
  • Ardsley Advisory Partners fully exited ProShares Trust UltraShort Lehman 20+ Year Treasury in Q2 2022, selling an estimated $21.1M.
  • Ardsley Advisory Partners's ten largest holdings make up 47% of its $608M portfolio in Q2 2022.
  • Ardsley Advisory Partners opened 59 new positions and closed 61 in Q2 2022.
  • Ardsley Advisory Partners's portfolio value rose 1.4% quarter-over-quarter to $608M.

Based on Ardsley Advisory Partners's 13F filing for Q2 2022, filed 15 Aug 2022.